Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 3/2001

01-05-2001 | Notas Clínicas

Bacteriemia causada por Leuconostoc spp. en una paciente con adenocarcinoma de ovario y neutropenia

Authors: María Luisa Limón Mirón, Manuel Chaves Conde, José Andrés Moreno Nogueira, Manuel Enrique Jiménez Mejías

Published in: Clinical and Translational Oncology | Issue 3/2001

Login to get access
Metadata
Title
Bacteriemia causada por Leuconostoc spp. en una paciente con adenocarcinoma de ovario y neutropenia
Authors
María Luisa Limón Mirón
Manuel Chaves Conde
José Andrés Moreno Nogueira
Manuel Enrique Jiménez Mejías
Publication date
01-05-2001
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 3/2001
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/BF02711443

Other articles of this Issue 3/2001

Clinical and Translational Oncology 3/2001 Go to the issue

Revisiones

Breast cancer: contribution of molecular biology to the management of the disease

Revisiones

Susceptibilidad genética individual y alteraciones moleculares en el cáncer de pulmón

Originales Breves

Oxaliplatino y fiebre: presentación de 4 casos

Originales

Multimodal treatment for squamous cell carcinoma of the esophagus: results with two different strategies

Originales

Variations in use of breast-conserving surgery by patient, hospital characteristics, and region: a multilevel analysis

Announcement

Información
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits